相关实验视频

Updated: May 27, 2025

In vitro Functional Characterization of Mouse Colorectal Afferent Endings

In vitro Functional Characterization of Mouse Colorectal Afferent Endings

Published on: January 21, 2015

电可以缓解由齐莫桑诱导的结肠直肠过敏症

L I Siting¹, Wang Shaojun¹, Yin Yehui¹

¹Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan

|February 17, 2025

概括

电针 (EA) 在刺激性肠综合征 (IBS) 的小鼠模型中显著降低了结肠直肠过敏. 这种疗法调节结直肠和脊髓中与疼痛相关的蛋白质表达,提供一种潜在的IBS治疗方法.

科学领域:

神经科学是一个神经科学.
胃肠病学胃肠病学
疼痛研究疼痛研究

背景情况:

刺激性肠综合征 (IBS) 的特征是结肠直肠过敏.
与IBS相关的疼痛的潜在机制尚未完全理解.
电针 (EA) 是一种潜在的治疗方法来治疗内脏疼痛.

研究的目的:

研究EA缓解结直肠过敏症的机制.
为了确定EA对结直肠和脊髓疼痛相关蛋白质表达的影响.

主要方法:

在小鼠中使用zymosan诱导了结肠直肠过敏模型.
采用了电生理学技术,西式涂抹和免疫光染色.
在EA后分析了结直肠敏感性,脊髓节和脊髓反应的变化.

主要成果:

在接受齐莫森治疗的小鼠中,EA治疗显著缓解了结肠直肠过敏症.
EA抑制了神经生长因子 (NGF),物质P (SP) 和短暂受体潜伏尼洛因1 (TRPV1) 的齐莫桑诱导的表达.
EA调节了NGF,SP,蛋白激酶C玛 (PKCγ) 和TRPV1在结直肠,脊髓和脊髓中的表达.

结论:

通过改变与疼痛相关的蛋白质表达,EA减轻了因齐莫桑诱导的结直肠过敏症.
EA显示出作为IBS治疗干预的潜力.
分子证据支持EA在调节IBS相关的疼痛途径方面的有效性.

关键词:

结直肠过敏症结直肠过敏症电针是一种电针.神经生长因子的神经生长因子蛋白质激酶C 玛玛物质 P 的物质 P 的物质 P.暂时的受体潜在通道.

更多相关视频

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

相关概念视频

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...